No statins before heart surgery, study suggests
(HealthDay)—Taking cholesterol-lowering statins right before heart surgery, once touted as a way to prevent common postoperative complications, has no benefit and may even cause harm, a new study...
View ArticleWhy are women less likely to be prescribed statins than men?
Statins are equally effective at decreasing risk of coronary events in men and women, and yet women are less likely to be prescribed these cholesterol-lowering drugs than men. A study by investigators...
View ArticleNewly diagnosed diabetes increases risk of heart attack, stroke even among...
Postmenopausal women with newly diagnosed diabetes have a significantly increased risk of atherosclerotic cardiovascular disease whether or not they take statin drugs, according to the results of a new...
View ArticleMajor review to help doctors, patients and public make informed decisions...
A major review of the available evidence on the safety and efficacy of statin therapy, published in The Lancet, intends to help doctors, patients and the public make informed decisions about the use of...
View ArticleLow statin use in people with diabetes despite cardioprotective effects,...
Nearly 2 out of 5 people with diabetes who could benefit from statin therapy to lower their risk of future heart attack, stroke and related death were not prescribed one, according to a research letter...
View ArticleEuropean, American guidelines lead to different recs for statins
(HealthDay)—European and American guidelines lead to different recommendations for statin therapy, according to a study published online Sept. 21 in JACC: Cardiovascular Imaging.
View ArticleStatins reduce risk of mortality in multiple myeloma
(HealthDay)—Statin therapy is associated with reduced risk of all-cause and multiple myeloma (MM)-specific mortality, according to a study published online Sept. 19 in the Journal of Clinical Oncology.
View ArticleCCS sets new guidelines for management of lipid metabolism disorders that...
The Canadian Cardiovascular Society (CCS) has published an important update to its guidelines for the management of dyslipidemia - lipid metabolism disorders - that can cause cardiovascular disease....
View ArticleHigh-intensity statins linked to better survival rates of cardiovascular...
A large national study has confirmed the value of high-intensity statin treatments for people with cardiovascular disease, according to researchers at the Stanford University School of Medicine.
View ArticleCholesterol lowering drugs cut risk of a first heart attack or stroke
Cholesterol-lowering drugs help prevent heart attacks and strokes in adults with cardiovascular risk factors such as high cholesterol, high blood pressure, diabetes and smoking, but have not yet had a...
View ArticleDietary supplement may carry both benefits and risks associated with statins
Red yeast rice (RYR) is contained in dietary supplements that are often used by patients with high cholesterol, and it is often proposed as an alternative therapy in those who experience side effects...
View ArticleHigh CVD risk in patients with head, neck squamous cell cancer
(HealthDay)—Twenty-three percent of patients with head and neck squamous cell carcinoma (HNSCC) have cardiovascular disease (CVD) at diagnosis, and 24 percent have uncontrolled blood pressure,...
View ArticleStudy suggests new drug alongside statins can significantly cut cholesterol
A new class of cholesterol-lowering drug has been found to help patients cut their risk of cardiovascular disease, stroke and heart attack.
View ArticleEvolocumab significantly reduces risk of cardiovascular events
Evolocumab, one of the new targeted PCSK9 inhibitor drugs that has been shown to dramatically lower levels of low-density lipoprotein (LDL), or "bad" cholesterol, also significantly lowers the risk of...
View ArticlePCSK9 inhibitor evolocumab not associated with decline in memory or cognitive...
New trial results show that in patients on statin therapy, the addition of evolocumab did not result in a significant change in cognitive function after 19 months of treatment.
View ArticleAfrican-Americans may receive different advice on statin therapy
African Americans experience a disproportionately high risk of cardiovascular disease, and statin treatment can be an important tool to lower the risk of plaque building up in the arteries.
View ArticleGuidelines differ on recommendations of statin treatment for African-Americans
Approximately 1 in 4 African American individuals recommended for statin therapy under guidelines from the American College of Cardiology/American Heart Association are no longer recommended for statin...
View ArticleAdherence to USPSTF recommendations could lead to lower number of individuals...
Fewer people could be recommended for primary prevention statin therapy, including many younger adults with high long-term cardiovascular disease risk, if physicians adhere to the 2016 U.S. Preventive...
View ArticleEstimating cost when it comes to novel therapies
When it comes to patient care, finding the best treatment can sometimes include finding an equal, yet more economical solution. Rather than introducing a costly new medication, for some patients...
View ArticlePatients nearing end of life receptive to having cholesterol medicine...
New research suggests patients nearing the end of their lives because of a "life-limiting illness" such as cancer or heart disease may not feel medically abandoned if their doctor wants to take them...
View ArticleBenefits of continued statin use after adverse reactions
Statins are known to reduce the risk of death and cardiovascular events for people who are at high risk; however, as many as 75 percent of patients discontinue statin therapy within two years, often...
View ArticleContinuing statin after adverse Rx tied to lower cardiac risk
(HealthDay)—For patients with an adverse reaction to a statin, continued statin prescriptions are associated with lower incidence of cardiovascular events and death, according to a study published...
View ArticleQuitting statins after stroke may raise risk of another stroke
Stroke patients who stopped taking statin drugs three to six months after a first ischemic stroke, the type caused by narrowed arteries, had a higher risk of a having another stroke within a year,...
View ArticleLess than half of stroke patients nationwide are prescribed recommended...
Nationwide, less than half of stroke patients discharged from the hospital received a prescription for cholesterol-lowering medications called statins, and the likelihood of a prescription varied by...
View ArticleEvolocumab doesn't affect cognition when added to statins
(HealthDay)—There is no significant difference in cognitive function for patients treated with evolocumab or placebo added to statin therapy, according to a study published in the Aug. 17 issue of the...
View ArticleResearchers identify strategies to optimize statin treatment for muscle symptoms
Statins are highly effective for preventing heart attacks by reducing low-density lipoprotein or "bad" cholesterol. However, 10 to 20 percent of patients taking statins report muscle-related symptoms...
View ArticleNonadherence to statins plus ACEIs/ARBs risky post MI
(HealthDay)—Nonadherence to angiotensin-converting enzyme (ACE) inhibitors/angiotensin II receptor blockers (ARBs) and/or statins following acute myocardial infarction (AMI) is associated with higher...
View ArticleACE inhibitor, statin no benefit for T1DM, high albumin excretion
(HealthDay)—For adolescents with type 1 diabetes and high levels of albumin excretion, neither angiotensin-converting-enzyme (ACE) inhibitors nor statins change the albumin-to-creatinine ratio over...
View ArticleHIV-positive adults are under-treated for cardiovascular problems compared to...
People with both HIV and risk factors for heart disease and stroke were less likely to be treated with cholesterol-lowering statin drugs and aspirin than patients without HIV. The researchers believe...
View ArticleSkin immunization by microneedle patch overcomes statin-induced suppression...
Statin therapy is prescribed for 20 percent of the US population over the age of 40 and nearly 50 percent of the population over 75 years old to reduce the risk of cardiovascular disease by lowering...
View Article
